BA
GDRX icon

Bridgewater Associates’s GoodRx Holdings GDRX Stock Holding History

Bridgewater Associates’s Portfolio GDRX Stock Details GDRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-149,062
Closed -$932K – 729
2023
Q1 		$932K Sell
149,062
-52,153
-26% -$291K 0.01% 572
2022
Q4 		$938K Sell
201,215
-23,602
-10% -$116K 0.01% 651
2022
Q3 		$1.05M Sell
224,817
-15,602
-6% -$98.4K 0.01% 693
2022
Q2 		$1.42M Sell
240,419
-2,359
-1% -$26.3K 0.01% 742
2022
Q1 		$4.69M Buy
242,778
+93,844
+63% +$2.15M 0.02% 487
2021
Q4 		$4.87M Sell
148,934
-541,949
-78% -$21.8M 0.03% 304
2021
Q3 		$28.3M Sell
690,883
-20,795
-3% -$754K 0.16% 109
2021
Q2 		$25.6M Buy
+711,678
New +$26.3M 0.16% 108

Other funds holding GDRX

FPM
Francisco Partners Management San Francisco, California $292M AUM 34.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SLG
Silver Lake Group Menlo Park, California $3.68B AUM 7.22% 1-Year Est. Return
PTC
Petrus Trust Company Dallas, Texas $915M AUM 2.95% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
TCMX
Technology Crossover Management X Menlo Park, California $781M AUM 18.39% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bridgewater Associates's GDRX Position: Q2 2023 in Review

Bridgewater Associates sold out of GoodRx Holdings (GDRX) in Q2 2023, closing a stake of 149,062 shares — an estimated $932K sold.

Bridgewater Associates first reported a position in GDRX in Q2 2021 and held it in 8 quarters. The position peaked at $28.3M in Q3 2021. 147 funds tracked by Wall St. Rank hold GDRX as of Q2 2023.

  • Bridgewater Associates reported no remaining GoodRx Holdings position as of Q2 2023 after selling out during the quarter.
  • Bridgewater Associates sold 149,062 GoodRx Holdings shares in Q2 2023, an estimated $932K.
  • Bridgewater Associates first reported a position in GoodRx Holdings in Q2 2021 and held it in 8 quarters.
  • Bridgewater Associates's GoodRx Holdings position peaked at $28.3M in Q3 2021.
  • 147 funds tracked by Wall St. Rank held GoodRx Holdings as of Q2 2023.

Based on Bridgewater Associates's 13F filing for Q2 2023, filed 11 Aug 2023.